You are here

Mounjaro

How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets

How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets

Medical Marketing and Media

Flag link:

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

BioSpace

Flag link:

Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist

Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist

Reuters

Flag link:

Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide

Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide

Fierce Biotech

muscle regeneration

Flag link:

Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro

Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro

Stat

Flag link:

Eli Lilly sues 11 online pharmacies for allegedly selling unauthorized versions of Mounjaro

Eli Lilly sues 11 online pharmacies for allegedly selling unauthorized versions of Mounjaro

Fierce Pharma

online pharmacies

drug counterfeiting

Flag link:

Eli Lilly plans diabetes drug trial for kids as young as 6 years - Bloomberg

Eli Lilly plans diabetes drug trial for kids as young as 6 years - Bloomberg

Yahoo/Reuters

clinical trials

Flag link:

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Forbes

Flag link:

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

CP Wire/Businesswire

Flag link:

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Flag link:

Why Eli Lilly Stock Crawled Higher Today

Why Eli Lilly Stock Crawled Higher Today

Motley Fool

Flag link:

2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not

2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not

Motley Fool

Flag link:

Lilly names new diabetes and obesity chief as Mounjaro sales take off

Lilly names new diabetes and obesity chief as Mounjaro sales take off

BioPharma Dive

Flag link:

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

CNBC

Flag link:

NICE changes its mind on Lilly's Mounjaro for diabetes

NICE changes its mind on Lilly's Mounjaro for diabetes

Pharmaphorum

Flag link:

Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85%

Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85%

CNBC

Flag link:

Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines

Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines

Fierce Pharma

Flag link:

Lilly's obesity drug leads to about 26% weight loss in new studies

Lilly's obesity drug leads to about 26% weight loss in new studies

Yahoo/Reuters

clinical trials

Flag link:

Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval

Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval

Fierce Pharma

Flag link:

New weight loss drugs carry high price tags and lots of questions for seniors

New weight loss drugs carry high price tags and lots of questions for seniors

Medical Marketing and Media

Flag link:

Pages